Stratrix
Competitors · Henry Schein

Who are Henry Schein’s competitors?

Henry Schein names 21 companies as competitors in its latest annual report, on 5 fronts. 3 companies name Henry Schein back.

Skip to the field, head to head ↓Henry Schein company profile

Competitors it names2110-K for fiscal 2025
Companies that name it3in their own annual reports
Revenue, 2025$13.2B+4% on a year
Net margin3%McKesson 1% · Patterson Companies 3%
Stratrix’s Take

Henry Schein has no single rival, only a different one for each thing it sells

Henry Schein names 21 competitors, but they don't form one field. Patterson Companies and Benco Dental Supply meet it in U.S. dental distribution. Geistlich Pharma and Botiss Biomaterials GmbH meet it in biomaterials. Straumann, Envista, Zimvie and Dentsply Sirona meet it in implants. Vyne Medical, Dental Intelligence and Weave Communications meet it in software. Each is its own contest.

The rivals see it the same way, from their own corner. Patterson Companies lists Henry Schein among its dental supply competitors. ZimVie lists it beside Straumann and Dentsply Sirona. Medline's list of med-surg distributors includes it, next to McKesson. One company shows up on three different maps, in three different roles.

The scale changes with each contest. Henry Schein earned $13.2 billion at a 3% net margin. Medline earned $28.4 billion at 4%. Dentsply Sirona earned $3.7 billion, Envista $2.7 billion, and ZimVie $450 million. No single customer topped 2% of Henry Schein's net sales, so it wins or loses one customer at a time. The useful question isn't who beats Henry Schein. It is where.

The fronts

Where Henry Schein says it competes

Dental distribution competitors in U.S
Patterson CompaniesBenco Dental Supply
“In the dental distribution market, our primary competitors in the U.S. are the Patterson Dental division of Patterson Companies, Inc. and Benco Dental Supply Company.”
In its own words · 10-K for fiscal 2025
Biomaterials for dental tissue regeneration
Geistlich PharmaBotiss Biomaterials GmbH
“These companies, along with Geistlich Pharma AG and Botiss Biomaterials GmbH, also compete with us in the biomaterials for dental tissue regeneration market.”
In its own words · 10-K for fiscal 2025
Large competing dental and medical distributors
Cadence GroupProclinic GroupDD GroupNuent GroupLifco ABPlanmeca GroupDental Union
“We compete on the basis of price and customer service against several large competitors, including Cadence Group, Proclinic Group, DD Group, Nuent Group, Lifco AB, Planmeca Group, Dental Union, and Dental Bauer”
In its own words · 10-K for fiscal 2025
Dental implant competitors
“our primary global competitors include Straumann, Envista, Zimvie, and Dentsply Sirona for dental implants”
In its own words · 10-K for fiscal 2025
Dental practice software vendors
Vyne MedicalDental IntelligenceWeave Communications
“In other software end markets, including revenue cycle management, patient relationship management and patient demand generation, we compete with companies such as Vyne Medical, Dental Intelligence, and Weave Communications, Inc.”
In its own words · 10-K for fiscal 2025
Also named
Dental BauerMcKessonMedline Industries
Named back

Who names Henry Schein as a competitor

“Additionally, other distributors of med-surg products similarly connect the fragmented supplier and provider bases and aggregate inventory from suppliers to deliver products to customers, such as McKesson, Cardinal Health, Owens & Minor, and Henry Schein.”

10-K for 2025
ZimVie2024

“We compete primarily with The Straumann Group, Dentsply Sirona Inc., Nobel Biocare Services AG (part of Envista Holdings Corporation), Henry Schein, Inc. and Geistlich Pharma AG.”

10-K for 2024

“In the U.S. and Canadian dental supply market, we compete against Henry Schein, Inc., Benco Dental Supply Company, Burkhart Dental Supply and hundreds of distributors that operate on a regional or local level, or online.”

10-K for 2024
Head to head

The field, from the filings

CompanyFiscal yearRevenueGrowthNet marginEmployees
Henry Schein2025$13.2B+4%3%25,000
McKessonFY to Mar 2026$403.4B+12%1%43,000
Medline2025$28.4B+11%4%45,000
Patterson CompaniesFY to Apr 2024$6.6B+1%3%7,600
Dentsply Sirona2025$3.7B−3%−16%–
Envista Holdings2025$2.7B+8%2%12,000
ZimVie2024$450M−2%−6%1,770

Each company’s latest fiscal year as reported to the SEC, in US dollars; fiscal years end in different months. Rivals that report outside the US or in other currencies are not shown.

Customers

How concentrated Henry Schein’s customers are

“No single customer accounted for more than 2 % of our net sales in each of the years ended December 27, 2025, December 28, 2024 or December 30, 2023.”
In its own words · 10-K for fiscal 2025
The moves

What the rivals have done lately

McKessonAcquired PRISM Vision Holdings

“On April 2, 2025, we announced the completion of our previously announced acquisition of a controlling interest in PRISM Vision Holdings, LLC (“PRISM Vision”), a leading provider of general ophthalmology and retina management services.” filing

Patterson CompaniesAcquired Relief Services for Veterinary Practitioners and Animal Care Technologies

“During the third quarter of fiscal 2023, we acquired substantially all of the assets of Relief Services for Veterinary Practitioners and Animal Care Technologies (RSVP and ACT), Texas-based companies that provide innovative solutions to …” filing

Patterson CompaniesAcquired Dairy Tech

“Also during the third quarter of fiscal 2023, we acquired substantially all of the assets of Dairy Tech, Inc., a Colorado-based company that provides pasteurizing equipment and single-use bags that allow dairy producers to produce, store…” filing

Questions

Asked about Henry Schein’s competitors

Who are Henry Schein's competitors?

In its annual report for fiscal 2025, Henry Schein names 21 competitors across 5 fronts: dental distribution competitors in u.s, biomaterials for dental tissue regeneration, large competing dental and medical distributors, dental implant competitors and dental practice software vendors. 10-K for fiscal 2025

Which companies name Henry Schein as a competitor?

3 companies in our coverage name it in their own annual reports: Medline, ZimVie and Patterson Companies.

How does Henry Schein compare with its rivals?

Henry Schein reported $13.2B in revenue in its latest fiscal year, +4% on a year, with a 3% net margin. McKesson: $403.4B, 1% net margin; Patterson Companies: $6.6B, 3% net margin.

What are the alternatives to Henry Schein?

The companies Henry Schein itself names as competitors are listed above, front by front, each in its own report’s words. Which matters for a given buyer depends on the job, not the list.

Is your best customer building your replacement?

How much of your revenue comes from somebody who is also trying to replace you?

See the pack →

Sources: Henry Schein’s annual report for fiscal 2025; the annual reports of the companies that name it; each company’s financial data as reported to the SEC; Stratrix Decision Records. Analysis and data, not advice.

For information and strategic analysis only, not investment advice. Stratrix does not recommend buying, selling or holding any security.

Tools to try

More from Stratrix

The Business Model Wizard

Make the seven choices that define your model, test your numbers against real companies, and meet the rival AI would build against you.

Free · about twelve minutesBuild your Model Thesis →

Weekly email

Stratonomics, every Tuesday

One data story every Tuesday: what happened, what it means, and the figures you can quote. Free.

We'll email you a link to confirm. Unsubscribe anytime. Privacy policy.